NCT03394365 · Interventional trial
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Overall registry status Recruiting
Phase 3
Conditions Allogeneic Hematopoietic Cell Transplant, Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Lymphoproliferative Disorders, Solid Organ Transplant Complications, Stem Cell Transplant Complications
Delaware Valley sites
- Hospital of the University of Pennsylvania (Adults only) · Philadelphia, PA · Philadelphia County · Recruiting
- The Children's Hospital of Philadelphia Oncology Division, Blood & Marrow Transplant Section (Pediatrics) · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory